Page last updated: 2024-08-21

nicotinamide mononucleotide and Liver Cirrhosis

nicotinamide mononucleotide has been researched along with Liver Cirrhosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, Y; Deng, H; Liu, J; Liu, X; Wang, N; Wang, Q; Yang, C; Zhang, W; Zong, Z1
Akhanov, V; Amano, H; Baur, JA; Catic, A; Chang, JT; Chaudhury, A; Finegold, M; Johnson, H; Lopez-Berestein, G; Lu, L; Meeker, A; Nakamaru-Ogiso, E; Neilson, JR; Popov, YV; Rodriguez-Aguayo, C; Sahin, E; Sinclair, DA; Stossi, F; Verdin, E1

Other Studies

2 other study(ies) available for nicotinamide mononucleotide and Liver Cirrhosis

ArticleYear
Nicotinamide mononucleotide inhibits hepatic stellate cell activation to prevent liver fibrosis via promoting PGE
    Free radical biology & medicine, 2021, Volume: 162

    Topics: Animals; Dinoprostone; Hepatic Stellate Cells; Liver; Liver Cirrhosis; Mice; Nicotinamide Mononucleotide; Thioacetamide

2021
Telomere Dysfunction Induces Sirtuin Repression that Drives Telomere-Dependent Disease.
    Cell metabolism, 2019, 06-04, Volume: 29, Issue:6

    Topics: Animals; Cells, Cultured; Down-Regulation; Embryo, Mammalian; Female; Gene Expression Regulation, Enzymologic; HEK293 Cells; Humans; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Liver; Nicotinamide Mononucleotide; Sirtuin 1; Sirtuins; Telomerase; Telomere Homeostasis; Telomere Shortening

2019